Celldex Therapeutics, Inc. (CLDX) Net Margin
- 2026-06-30: Net Margin -334104.55%.
- 2026-03-31: Net Margin -524566.67%.
- 2025-12-31: Net Margin -67204.13%.
- 2025-06-30: Net Margin -7753.42%.
Complete source-backed net margin history.
- Available history
- 2010-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -334104.55% |
| 2026-03-31 | -524566.67% |
| 2025-12-31 | -67204.13% |
| 2025-06-30 | -7753.42% |
| 2025-03-31 | -7740.43% |
| 2024-12-31 | -4007.83% |
| 2024-09-30 | -1319.99% |
| 2024-06-30 | -1434.83% |
| 2024-03-31 | -21030.77% |
| 2011-06-30 | -524.39% |
| 2010-06-30 | -322.77% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -16748.03% |
| 2024-12-31 | -2248.76% |
| 2023-12-31 | -2054.76% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |